CDH2 and cervical cancer: Similarly, in cervical cancer, CYB5D2 inhibits epithelial–mesenchymal transition (EMT) by upregulating E-cadherin and downregulating N-cadherin, Snail, and Twist, thereby reducing the invasiveness and metastatic ability of tumor cells [22].